15 July 2019
Pyrroluria - Medical Condition or Biomarker?
InterClinical eNews March 2019, Issue 90 This month's issue explores the evidence for Pyrroluria, and asks the question - is it a discrete medical condition or is it a biomarker of other pathology? We take a look into the history, research findings and treatment options. Detection Hydroxyhemopyrrolin-2-one (HPL) or "mauve factor" was first discovered in 1958 in the urine Dr Hoffer's psychiatric patients. It was named after the colour it appeared in chromatograph assays. It was later identified by a fellow researcher, Irvine, as...
